| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/08/2000 | US6023010 Transgenic non-human animals depleted in a mature lymphocytic cell-type |
| 02/08/2000 | US6022960 Nucleotide sequence coding a chimeric gonadotropin releasing hormone; for vaccine development |
| 02/08/2000 | US6022958 cDNAs coding for members of the carcinoembryonic antigen family |
| 02/08/2000 | US6022949 Protein which regulates fungal susceptibility to fungicide; for screening of fungicides; for producing modulators of fungicide |
| 02/08/2000 | US6022853 Morphogen-enriched dietary composition |
| 02/08/2000 | US6022848 Inhibitor of stem cell proliferation and uses thereof |
| 02/08/2000 | US6022735 Composition for introducing nucleic acid complexes into higher eucaryotic cells |
| 02/08/2000 | US6022704 Nucleic acid sequences coding mammalian neuron receptor; for detection of modulators of receptor activity; for treatment of brain disorders |
| 02/08/2000 | US6022546 Toxoplasma gondii antigens, the preparation thereof and the use thereof |
| 02/08/2000 | US6022542 Polypeptide which serves as reagent in diagnostic kit for detecting an anti-herpesvirus antibody present in a biological sample; kaposi's sarcoma (ks) and retroperitoneal fibromatosis (rf) |
| 02/08/2000 | US6022541 Immunological preparation for concurrent specific binding to spatially exposed regions of vascular permeability factor bound in-vivo to a tumor associated blood vessel |
| 02/08/2000 | US6022540 Ligands that modulate differentiation of mesenchymal stem cells |
| 02/08/2000 | CA2003794C Expression of hiv proteins in drosophila cells |
| 02/03/2000 | WO2000005585A1 Determination of the hydrophobic pulmonary surfactant protein sp-c |
| 02/03/2000 | WO2000005391A1 Antibody-mediated down-regulation of plant proteins |
| 02/03/2000 | WO2000005389A2 Production of proteins |
| 02/03/2000 | WO2000005388A1 Genes of the dead box protein family, their expression products and use |
| 02/03/2000 | WO2000005375A1 Gbs toxin receptor |
| 02/03/2000 | WO2000005374A2 Molecules associated with cell proliferation |
| 02/03/2000 | WO2000005371A1 Keratinocyte derived interferon |
| 02/03/2000 | WO2000005370A1 Orphan cytokine receptor |
| 02/03/2000 | WO2000005365A1 Human lcb kinase 1 |
| 02/03/2000 | WO2000005364A1 Protein similar to neuroendrocrine-specific protein, and encoding cdna |
| 02/03/2000 | WO2000005362A1 Mekk1(serine threonine kinases)-interacting fha (forkhead associated domain) protein 1 (mif1) |
| 02/03/2000 | WO2000005361A1 Human sbpsapl gene with homology to the prosaposin family of neurotrophic factors |
| 02/03/2000 | WO2000005348A1 Pneumococcal nrdg protein |
| 02/03/2000 | WO2000005345A1 Human thyrotropin receptor compositions and use thereof |
| 02/03/2000 | WO2000005268A1 Hybrid human/rodent igg antibody to cd3, and methods of its construction |
| 02/03/2000 | WO2000005267A1 Antibodies against beer spoilage lactic acid bacteria and their diagnostic use |
| 02/03/2000 | WO2000005266A1 Anti hepatitis c virus antibody and uses thereof |
| 02/03/2000 | WO2000005265A2 Anti-crr2 antibodies and methods of use therefor |
| 02/03/2000 | WO2000005259A1 Secreted cysteine rich protein-6 (scrp-6) |
| 02/03/2000 | WO2000005253A2 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
| 02/03/2000 | WO2000005244A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 02/03/2000 | WO2000004923A1 Scrp-5: secreted cysteine rich protein-5 |
| 02/03/2000 | WO2000004864A2 Agents that bind to and inhibit human cytochrome |
| 02/03/2000 | WO2000004863A2 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 02/03/2000 | WO2000004861A2 Agents that bind to and inhibit human cytochrome p450 2a6 |
| 02/03/2000 | WO2000004761A1 Receptor-like protein kinase, rkn, and methods of use for increasing growth and yield in plants |
| 02/03/2000 | WO2000004760A1 Copper transporter in ethylene signaling pathway |
| 02/03/2000 | WO1999065946A3 Methods to prepare antibodies which bind to posttranslationally modified amino acids within peptides |
| 02/03/2000 | WO1999065517A3 Therapeutic compositions that produce an immune response by altering the antigen |
| 02/03/2000 | WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors |
| 02/03/2000 | WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 02/03/2000 | WO1999061628A3 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase |
| 02/03/2000 | WO1999061475A8 Method for separating and/or isolating plasma proteins by annularchromatography |
| 02/03/2000 | WO1999059620A9 Angiostatin receptor |
| 02/03/2000 | WO1999058571A3 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof |
| 02/03/2000 | WO1999054349A3 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 02/03/2000 | WO1999052945A9 NOVEL MOLECULES OF THE BGCKr-RELATED PROTEIN FAMILY AND USES THEREOF |
| 02/03/2000 | WO1999052942A3 Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma |
| 02/03/2000 | DE19836090A1 Avian vitelline antibody directed against soil urease useful for quantifying urease in the soil by immunoassay |
| 02/03/2000 | DE19836084A1 Avian vitelline antibody against ammonifying microorganisms, especially soil bacterium W7/15, useful for quantifying ammonifying microorganisms in the soil by immunoassay |
| 02/03/2000 | DE19831382A1 Humanes m¶3¶G-cap-spezifisches Kernimportrezeptorprotein mit einer neuen Domänenstruktur, dessen Herstellung und Verwendung Human m¶3¶G-cap-specific nuclear import receptor protein with a new domain tree, its preparation and use |
| 02/03/2000 | CA2714833A1 Vaccines against escherichia coli o157 infection |
| 02/03/2000 | CA2339045A1 Anti hepatitis c virus antibody and uses thereof |
| 02/03/2000 | CA2338561A1 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
| 02/03/2000 | CA2338299A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 02/03/2000 | CA2337093A1 Receptor-like protein kinase, rkn, and methods of use for increasing growth and yield in plants |
| 02/03/2000 | CA2336487A1 Copper transporter in ethylene signaling pathway |
| 02/03/2000 | CA2336250A1 Anti-ccr2 antibodies and methods of use therefor |
| 02/03/2000 | CA2335655A1 Keratinocyte derived interferon |
| 02/03/2000 | CA2335653A1 Molecules associated with cell proliferation |
| 02/03/2000 | CA2335646A1 Genes of the dead box protein family, their expression products and use |
| 02/03/2000 | CA2335345A1 Human calcium regulatory proteins |
| 02/03/2000 | CA2334047A1 Hybrid human/rodent igg antibody to cd3, and methods of its construction |
| 02/03/2000 | CA2334042A1 Orphan cytokine receptor |
| 02/03/2000 | CA2333302A1 Antibodies for the dectection of beer spoilage lactic acid bacteria, method of detection using the antibodies, and kit employing the antibodies |
| 02/03/2000 | CA2328449A1 Antibody-mediated down-regulation of plant proteins |
| 02/02/2000 | EP0976765A1 Process for the preparation of a protein solution |
| 02/02/2000 | EP0976759A2 Preparation of protein formulations with reduced content of aggregates |
| 02/02/2000 | EP0975971A1 Methods for detecting cell apoptosis |
| 02/02/2000 | EP0975964A1 In situ identification of target structures e.g. in vivo selection method for a phage library |
| 02/02/2000 | EP0975963A1 Prostate specific antigen substrates |
| 02/02/2000 | EP0975801A1 METHODS FOR SCREENING FOR ANTIMICROBIALS UTILIZING (aarC) AND COMPOSITIONS THEREOF |
| 02/02/2000 | EP0975798A1 Method to diagnose and treat pathological conditions resulting from deficient ion transport such as pseudohypoaldosteronism type-1 |
| 02/02/2000 | EP0975772A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
| 02/02/2000 | EP0975769A1 Novel prostate-associated kallikrein |
| 02/02/2000 | EP0975765A1 Plant fatty acid epoxygenase genes and uses therefor |
| 02/02/2000 | EP0975760A1 Motilin homologs |
| 02/02/2000 | EP0975759A1 Human tumor-associated kazal inhibitor |
| 02/02/2000 | EP0975758A1 POLYPEPTIDE HAVING A GTPase REGULATOR ACTIVITY, NUCLEIC ACIDS CODING THEREFOR AND THEIR USE IN DIAGNOSTICS AND THERAPY |
| 02/02/2000 | EP0975755A1 Crsp protein (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor |
| 02/02/2000 | EP0975754A1 Osteoprotegerin binding proteins and receptors |
| 02/02/2000 | EP0975753A2 $g(b)-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME |
| 02/02/2000 | EP0975752A1 Human cerberus protein |
| 02/02/2000 | EP0975751A1 A tm4sf human tumor-associated antigen |
| 02/02/2000 | EP0975748A1 Methods dor identifying nucleic acid molecules encoding (poly)peptides that interact with target molecules |
| 02/02/2000 | EP0975680A1 Interactive system for substance presentation and elimination |
| 02/02/2000 | EP0975674A1 Immunotoxins, comprising an onc protein, directed against malignant cells |
| 02/02/2000 | EP0975673A2 Determination of recombinant glycosylated proteins and peptides in biological fluids |
| 02/02/2000 | EP0975672A1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 02/02/2000 | EP0975668A1 MODIFIED TNF$g(a) MOLECULES, DNA ENCODING SUCH MODIFIED TNF$g(a) MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNF$g(a) MOLECULES AND DNA |
| 02/02/2000 | EP0975664A1 Aatt promoter element and transcription factor |
| 02/02/2000 | EP0975657A1 Method of purifying protein from inclusion bodies |
| 02/02/2000 | EP0975380A2 Membrane system for controlled tissue regeneration in cases of diseases of the peridontium |
| 02/02/2000 | EP0975361A1 Methods of modulating immune coagulation |
| 02/02/2000 | EP0975355A2 Hexameric fusion proteins and uses therefor |
| 02/02/2000 | EP0866859A4 Urogenital sinus derived growth factor nucleotide and amino acid sequences |
| 02/02/2000 | EP0713529B1 Growth differentiation factor of the TGF-B family |